COVID-19: A Recommendation to Examine the Effect of Mouthrinses with β-Cyclodextrin Combined with Citrox in Preventing Infection and Progression.
Identifieur interne : 001451 ( Main/Exploration ); précédent : 001450; suivant : 001452COVID-19: A Recommendation to Examine the Effect of Mouthrinses with β-Cyclodextrin Combined with Citrox in Preventing Infection and Progression.
Auteurs : Florence Carrouel [France] ; Maria Pia Conte [Italie] ; Julian Fisher [États-Unis] ; Lucio Souza Gonçalves [Brésil] ; Claude Dussart [France] ; Juan Carlos Llodra [Espagne] ; Denis Bourgeois [France]Source :
- Journal of clinical medicine [ 2077-0383 ] ; 2020.
Abstract
Considered to be a major portal of entry for infectious agents, the oral cavity is directly associated with the evolutionary process of SARS-CoV-2 in its inhalation of ambient particles in the air and in expectorations. Some new generations of mouth rinses currently on the market have ingredients that could contribute to lower the SARS-CoV-2 viral load, and thus facilitate the fight against oral transmission. If chlorhexidine, a usual component of mouth rinse, is not efficient to kill SARS-CoV-2, the use of a mouth rinses and/or with local nasal applications that contain β-cyclodextrins combined with flavonoids agents, such as Citrox, could provide valuable adjunctive treatment to reduce the viral load of saliva and nasopharyngeal microbiota, including potential SARS-CoV-2 carriage. We urge national agencies and authorities to start clinical trials to evaluate the preventive effects of βCD-Citrox therapeutic oral biofilm rinses in reducing the viral load of the infection and possibly disease progression.
DOI: 10.3390/jcm9041126
PubMed: 32326426
PubMed Central: PMC7230644
Affiliations:
- Brésil, Espagne, France, Italie, États-Unis
- Andalousie, Auvergne-Rhône-Alpes, Latium, Rhône-Alpes, État de New York, État de Rio de Janeiro
- Grenade (Espagne), Lyon, Rio de Janeiro, Rome
- Université de Grenade
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">COVID-19: A Recommendation to Examine the Effect of Mouthrinses with β-Cyclodextrin Combined with Citrox in Preventing Infection and Progression.</title><author><name sortKey="Carrouel, Florence" sort="Carrouel, Florence" uniqKey="Carrouel F" first="Florence" last="Carrouel">Florence Carrouel</name><affiliation wicri:level="3"><nlm:affiliation>University Lyon 1, Laboratory "Health Systemic Process", EA4129, 69008 Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>University Lyon 1, Laboratory "Health Systemic Process", EA4129, 69008 Lyon</wicri:regionArea><placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region><region type="old region" nuts="2">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Conte, Maria Pia" sort="Conte, Maria Pia" uniqKey="Conte M" first="Maria Pia" last="Conte">Maria Pia Conte</name><affiliation wicri:level="1"><nlm:affiliation>Sapienza University of Rome, Department of Public Health and Infectious Diseases, 00185 Rome, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Sapienza University of Rome, Department of Public Health and Infectious Diseases, 00185 Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation></author><author><name sortKey="Fisher, Julian" sort="Fisher, Julian" uniqKey="Fisher J" first="Julian" last="Fisher">Julian Fisher</name><affiliation wicri:level="2"><nlm:affiliation>THEnet, Training for Health Equity Network, New York, NY 10023, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>THEnet, Training for Health Equity Network, New York, NY 10023</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Goncalves, Lucio Souza" sort="Goncalves, Lucio Souza" uniqKey="Goncalves L" first="Lucio Souza" last="Gonçalves">Lucio Souza Gonçalves</name><affiliation wicri:level="1"><nlm:affiliation>Estacio de Sá University, Faculty of Dentistry, Rio de Janeiro 22640-102, Brazil.</nlm:affiliation><country xml:lang="fr">Brésil</country><wicri:regionArea>Estacio de Sá University, Faculty of Dentistry, Rio de Janeiro 22640-102</wicri:regionArea><placeName><settlement type="city">Rio de Janeiro</settlement><region type="state">État de Rio de Janeiro</region></placeName></affiliation></author><author><name sortKey="Dussart, Claude" sort="Dussart, Claude" uniqKey="Dussart C" first="Claude" last="Dussart">Claude Dussart</name><affiliation wicri:level="3"><nlm:affiliation>Lyon Public Hospices, Central Pharmacy, EA4129, 69002 Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Lyon Public Hospices, Central Pharmacy, EA4129, 69002 Lyon</wicri:regionArea><placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region><region type="old region" nuts="2">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Llodra, Juan Carlos" sort="Llodra, Juan Carlos" uniqKey="Llodra J" first="Juan Carlos" last="Llodra">Juan Carlos Llodra</name><affiliation wicri:level="4"><nlm:affiliation>University of Granada, Department of Preventive and Community Dentistry, 18010 Granada, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>University of Granada, Department of Preventive and Community Dentistry, 18010 Granada</wicri:regionArea><placeName><region nuts="2" type="communauté">Andalousie</region><settlement type="city">Grenade (Espagne)</settlement></placeName><orgName type="university">Université de Grenade</orgName></affiliation></author><author><name sortKey="Bourgeois, Denis" sort="Bourgeois, Denis" uniqKey="Bourgeois D" first="Denis" last="Bourgeois">Denis Bourgeois</name><affiliation wicri:level="3"><nlm:affiliation>University Lyon 1, Laboratory "Health Systemic Process", EA4129, 69008 Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>University Lyon 1, Laboratory "Health Systemic Process", EA4129, 69008 Lyon</wicri:regionArea><placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region><region type="old region" nuts="2">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32326426</idno><idno type="pmid">32326426</idno><idno type="doi">10.3390/jcm9041126</idno><idno type="pmc">PMC7230644</idno><idno type="wicri:Area/Main/Corpus">001622</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001622</idno><idno type="wicri:Area/Main/Curation">001622</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001622</idno><idno type="wicri:Area/Main/Exploration">001622</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">COVID-19: A Recommendation to Examine the Effect of Mouthrinses with β-Cyclodextrin Combined with Citrox in Preventing Infection and Progression.</title><author><name sortKey="Carrouel, Florence" sort="Carrouel, Florence" uniqKey="Carrouel F" first="Florence" last="Carrouel">Florence Carrouel</name><affiliation wicri:level="3"><nlm:affiliation>University Lyon 1, Laboratory "Health Systemic Process", EA4129, 69008 Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>University Lyon 1, Laboratory "Health Systemic Process", EA4129, 69008 Lyon</wicri:regionArea><placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region><region type="old region" nuts="2">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Conte, Maria Pia" sort="Conte, Maria Pia" uniqKey="Conte M" first="Maria Pia" last="Conte">Maria Pia Conte</name><affiliation wicri:level="1"><nlm:affiliation>Sapienza University of Rome, Department of Public Health and Infectious Diseases, 00185 Rome, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Sapienza University of Rome, Department of Public Health and Infectious Diseases, 00185 Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation></author><author><name sortKey="Fisher, Julian" sort="Fisher, Julian" uniqKey="Fisher J" first="Julian" last="Fisher">Julian Fisher</name><affiliation wicri:level="2"><nlm:affiliation>THEnet, Training for Health Equity Network, New York, NY 10023, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>THEnet, Training for Health Equity Network, New York, NY 10023</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Goncalves, Lucio Souza" sort="Goncalves, Lucio Souza" uniqKey="Goncalves L" first="Lucio Souza" last="Gonçalves">Lucio Souza Gonçalves</name><affiliation wicri:level="1"><nlm:affiliation>Estacio de Sá University, Faculty of Dentistry, Rio de Janeiro 22640-102, Brazil.</nlm:affiliation><country xml:lang="fr">Brésil</country><wicri:regionArea>Estacio de Sá University, Faculty of Dentistry, Rio de Janeiro 22640-102</wicri:regionArea><placeName><settlement type="city">Rio de Janeiro</settlement><region type="state">État de Rio de Janeiro</region></placeName></affiliation></author><author><name sortKey="Dussart, Claude" sort="Dussart, Claude" uniqKey="Dussart C" first="Claude" last="Dussart">Claude Dussart</name><affiliation wicri:level="3"><nlm:affiliation>Lyon Public Hospices, Central Pharmacy, EA4129, 69002 Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Lyon Public Hospices, Central Pharmacy, EA4129, 69002 Lyon</wicri:regionArea><placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region><region type="old region" nuts="2">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Llodra, Juan Carlos" sort="Llodra, Juan Carlos" uniqKey="Llodra J" first="Juan Carlos" last="Llodra">Juan Carlos Llodra</name><affiliation wicri:level="4"><nlm:affiliation>University of Granada, Department of Preventive and Community Dentistry, 18010 Granada, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>University of Granada, Department of Preventive and Community Dentistry, 18010 Granada</wicri:regionArea><placeName><region nuts="2" type="communauté">Andalousie</region><settlement type="city">Grenade (Espagne)</settlement></placeName><orgName type="university">Université de Grenade</orgName></affiliation></author><author><name sortKey="Bourgeois, Denis" sort="Bourgeois, Denis" uniqKey="Bourgeois D" first="Denis" last="Bourgeois">Denis Bourgeois</name><affiliation wicri:level="3"><nlm:affiliation>University Lyon 1, Laboratory "Health Systemic Process", EA4129, 69008 Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>University Lyon 1, Laboratory "Health Systemic Process", EA4129, 69008 Lyon</wicri:regionArea><placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region><region type="old region" nuts="2">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author></analytic><series><title level="j">Journal of clinical medicine</title><idno type="ISSN">2077-0383</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Considered to be a major portal of entry for infectious agents, the oral cavity is directly associated with the evolutionary process of SARS-CoV-2 in its inhalation of ambient particles in the air and in expectorations. Some new generations of mouth rinses currently on the market have ingredients that could contribute to lower the SARS-CoV-2 viral load, and thus facilitate the fight against oral transmission. If chlorhexidine, a usual component of mouth rinse, is not efficient to kill SARS-CoV-2, the use of a mouth rinses and/or with local nasal applications that contain β-cyclodextrins combined with flavonoids agents, such as Citrox, could provide valuable adjunctive treatment to reduce the viral load of saliva and nasopharyngeal microbiota, including potential SARS-CoV-2 carriage. We urge national agencies and authorities to start clinical trials to evaluate the preventive effects of βCD-Citrox therapeutic oral biofilm rinses in reducing the viral load of the infection and possibly disease progression.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32326426</PMID><DateRevised><Year>2020</Year><Month>05</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Apr</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>COVID-19: A Recommendation to Examine the Effect of Mouthrinses with β-Cyclodextrin Combined with Citrox in Preventing Infection and Progression.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">E1126</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm9041126</ELocationID><Abstract><AbstractText>Considered to be a major portal of entry for infectious agents, the oral cavity is directly associated with the evolutionary process of SARS-CoV-2 in its inhalation of ambient particles in the air and in expectorations. Some new generations of mouth rinses currently on the market have ingredients that could contribute to lower the SARS-CoV-2 viral load, and thus facilitate the fight against oral transmission. If chlorhexidine, a usual component of mouth rinse, is not efficient to kill SARS-CoV-2, the use of a mouth rinses and/or with local nasal applications that contain β-cyclodextrins combined with flavonoids agents, such as Citrox, could provide valuable adjunctive treatment to reduce the viral load of saliva and nasopharyngeal microbiota, including potential SARS-CoV-2 carriage. We urge national agencies and authorities to start clinical trials to evaluate the preventive effects of βCD-Citrox therapeutic oral biofilm rinses in reducing the viral load of the infection and possibly disease progression.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Carrouel</LastName><ForeName>Florence</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University Lyon 1, Laboratory "Health Systemic Process", EA4129, 69008 Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conte</LastName><ForeName>Maria Pia</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Sapienza University of Rome, Department of Public Health and Infectious Diseases, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fisher</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>THEnet, Training for Health Equity Network, New York, NY 10023, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonçalves</LastName><ForeName>Lucio Souza</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Estacio de Sá University, Faculty of Dentistry, Rio de Janeiro 22640-102, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dussart</LastName><ForeName>Claude</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Lyon Public Hospices, Central Pharmacy, EA4129, 69002 Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Llodra</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>University of Granada, Department of Preventive and Community Dentistry, 18010 Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bourgeois</LastName><ForeName>Denis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University Lyon 1, Laboratory "Health Systemic Process", EA4129, 69008 Lyon, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">2019-nCoV</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Citrox</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">microbiome</Keyword><Keyword MajorTopicYN="N">mouthrinse</Keyword><Keyword MajorTopicYN="N">oral cavity</Keyword><Keyword MajorTopicYN="N">viral load</Keyword><Keyword MajorTopicYN="N">β-cyclodextrins</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>03</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>04</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32326426</ArticleId><ArticleId IdType="pii">jcm9041126</ArticleId><ArticleId IdType="doi">10.3390/jcm9041126</ArticleId><ArticleId IdType="pmc">PMC7230644</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Front Cell Infect Microbiol. 2014 Jun 26;4:85</Citation><ArticleIdList><ArticleId IdType="pubmed">25019064</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Pharmacol. 1997;38:151-63</Citation><ArticleIdList><ArticleId IdType="pubmed">8895808</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Opin Drug Deliv. 2005 Mar;2(2):335-51</Citation><ArticleIdList><ArticleId IdType="pubmed">16296758</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2000 Sep 24;276(2):534-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11027509</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioorg Med Chem. 2010 Nov 15;18(22):7940-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20934345</ArticleId></ArticleIdList></Reference><Reference><Citation>Beilstein J Org Chem. 2016 Dec 7;12:2644-2662</Citation><ArticleIdList><ArticleId IdType="pubmed">28144335</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Adv. 2020 Jan 29;6(5):eaax9318</Citation><ArticleIdList><ArticleId IdType="pubmed">32064341</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Pharm. 2017 Oct 15;531(2):457-469</Citation><ArticleIdList><ArticleId IdType="pubmed">28596142</ArticleId></ArticleIdList></Reference><Reference><Citation>Chem Biol Drug Des. 2019 Dec;94(6):2023-2030</Citation><ArticleIdList><ArticleId IdType="pubmed">31436895</ArticleId></ArticleIdList></Reference><Reference><Citation>Molecules. 2018 May 11;23(5):</Citation><ArticleIdList><ArticleId IdType="pubmed">29751694</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Microbiol. 2016 Jan 14;6:1529</Citation><ArticleIdList><ArticleId IdType="pubmed">26834707</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Microbiol. 1989 Oct;35(10):972-4</Citation><ArticleIdList><ArticleId IdType="pubmed">2819602</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2016 Jun 8;34(27):3191-3198</Citation><ArticleIdList><ArticleId IdType="pubmed">27160037</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Infect Dis. 2002 Jan;13(1):34-41</Citation><ArticleIdList><ArticleId IdType="pubmed">18159372</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pharm Sci. 1997 Feb;86(2):147-62</Citation><ArticleIdList><ArticleId IdType="pubmed">9040088</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2008 Jan 15;46(2):274-81</Citation><ArticleIdList><ArticleId IdType="pubmed">18171263</ArticleId></ArticleIdList></Reference><Reference><Citation>J Oral Maxillofac Pathol. 2019 Jan-Apr;23(1):122-128</Citation><ArticleIdList><ArticleId IdType="pubmed">31110428</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2018 Jan 25;14(1):e1006719</Citation><ArticleIdList><ArticleId IdType="pubmed">29370304</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Today. 2016 Feb;21(2):363-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26687191</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomolecules. 2019 Nov 28;9(12):</Citation><ArticleIdList><ArticleId IdType="pubmed">31795222</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Vaccine Immunol. 2006 Mar;13(3):319-28</Citation><ArticleIdList><ArticleId IdType="pubmed">16522772</ArticleId></ArticleIdList></Reference><Reference><Citation>Nanomaterials (Basel). 2020 Jan 13;10(1):</Citation><ArticleIdList><ArticleId IdType="pubmed">31941021</ArticleId></ArticleIdList></Reference><Reference><Citation>Retrovirology. 2008 Mar 27;5:29</Citation><ArticleIdList><ArticleId IdType="pubmed">18371227</ArticleId></ArticleIdList></Reference><Reference><Citation>Theranostics. 2017 Sep 26;7(17):4313-4321</Citation><ArticleIdList><ArticleId IdType="pubmed">29158828</ArticleId></ArticleIdList></Reference><Reference><Citation>Viruses. 2012 Nov 12;4(11):3044-68</Citation><ArticleIdList><ArticleId IdType="pubmed">23202515</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Mol Sci. 2019 Nov 22;20(23):</Citation><ArticleIdList><ArticleId IdType="pubmed">31766729</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Oral Sci. 2020 Mar 3;12(1):9</Citation><ArticleIdList><ArticleId IdType="pubmed">32127517</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2017 Jun 20;15(6):e2001930</Citation><ArticleIdList><ArticleId IdType="pubmed">28632753</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2016 Oct 25;10:CD008367</Citation><ArticleIdList><ArticleId IdType="pubmed">27778318</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pharmacol Sci. 2004 Nov;96(3):229-45</Citation><ArticleIdList><ArticleId IdType="pubmed">15539763</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Dent Hyg. 2012 Aug;10(3):209-22</Citation><ArticleIdList><ArticleId IdType="pubmed">22429551</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2020 Feb 12;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32047895</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Feb 22;395(10224):e39</Citation><ArticleIdList><ArticleId IdType="pubmed">32035510</ArticleId></ArticleIdList></Reference><Reference><Citation>Future Microbiol. 2012 Sep;7(9):1061-72</Citation><ArticleIdList><ArticleId IdType="pubmed">22953707</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Aug 29;9(8):e103234</Citation><ArticleIdList><ArticleId IdType="pubmed">25170958</ArticleId></ArticleIdList></Reference><Reference><Citation>Jpn Dent Sci Rev. 2019 Nov;55(1):33-40</Citation><ArticleIdList><ArticleId IdType="pubmed">30733843</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Nov 23;7(1):16127</Citation><ArticleIdList><ArticleId IdType="pubmed">29170411</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pharm Bioallied Sci. 2010 Apr;2(2):72-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21814436</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Mar 19;382(12):1177-1179</Citation><ArticleIdList><ArticleId IdType="pubmed">32074444</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Rev. 2000 Dec;52(4):673-751</Citation><ArticleIdList><ArticleId IdType="pubmed">11121513</ArticleId></ArticleIdList></Reference><Reference><Citation>J Glob Antimicrob Resist. 2017 Mar;8:159-163</Citation><ArticleIdList><ArticleId IdType="pubmed">28216018</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Today. 2016 Feb;21(2):356-62</Citation><ArticleIdList><ArticleId IdType="pubmed">26686054</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Pharm. 2013 Aug 30;453(1):167-80</Citation><ArticleIdList><ArticleId IdType="pubmed">22771733</ArticleId></ArticleIdList></Reference><Reference><Citation>J Dent. 2019 Jan;80 Suppl 1:S3-S12</Citation><ArticleIdList><ArticleId IdType="pubmed">30696553</ArticleId></ArticleIdList></Reference><Reference><Citation>Heliyon. 2018 Dec 28;4(12):e01067</Citation><ArticleIdList><ArticleId IdType="pubmed">30619958</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 2015 Feb;96(Pt 2):331-337</Citation><ArticleIdList><ArticleId IdType="pubmed">25381058</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2015 Mar 15;194(6):2673-82</Citation><ArticleIdList><ArticleId IdType="pubmed">25681338</ArticleId></ArticleIdList></Reference><Reference><Citation>J Nutr Sci. 2016 Dec 29;5:e47</Citation><ArticleIdList><ArticleId IdType="pubmed">28620474</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Opin Drug Deliv. 2009 Nov;6(11):1161-73</Citation><ArticleIdList><ArticleId IdType="pubmed">19705965</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Oral Health. 2016 Jul 18;17(1):19</Citation><ArticleIdList><ArticleId IdType="pubmed">27431672</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Environ Res Public Health. 2018 Nov 27;15(12):</Citation><ArticleIdList><ArticleId IdType="pubmed">30486374</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2020 May;92(5):479-490</Citation><ArticleIdList><ArticleId IdType="pubmed">32052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Br Dent J. 2011 Jan 8;210(1):E22</Citation><ArticleIdList><ArticleId IdType="pubmed">21217705</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Transl Med. 2018 Nov;6(21):426</Citation><ArticleIdList><ArticleId IdType="pubmed">30581834</ArticleId></ArticleIdList></Reference><Reference><Citation>Caries Res. 2002 Mar-Apr;36(2):93-100</Citation><ArticleIdList><ArticleId IdType="pubmed">12037365</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Brésil</li><li>Espagne</li><li>France</li><li>Italie</li><li>États-Unis</li></country><region><li>Andalousie</li><li>Auvergne-Rhône-Alpes</li><li>Latium</li><li>Rhône-Alpes</li><li>État de New York</li><li>État de Rio de Janeiro</li></region><settlement><li>Grenade (Espagne)</li><li>Lyon</li><li>Rio de Janeiro</li><li>Rome</li></settlement><orgName><li>Université de Grenade</li></orgName></list><tree><country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Carrouel, Florence" sort="Carrouel, Florence" uniqKey="Carrouel F" first="Florence" last="Carrouel">Florence Carrouel</name></region><name sortKey="Bourgeois, Denis" sort="Bourgeois, Denis" uniqKey="Bourgeois D" first="Denis" last="Bourgeois">Denis Bourgeois</name><name sortKey="Dussart, Claude" sort="Dussart, Claude" uniqKey="Dussart C" first="Claude" last="Dussart">Claude Dussart</name></country><country name="Italie"><region name="Latium"><name sortKey="Conte, Maria Pia" sort="Conte, Maria Pia" uniqKey="Conte M" first="Maria Pia" last="Conte">Maria Pia Conte</name></region></country><country name="États-Unis"><region name="État de New York"><name sortKey="Fisher, Julian" sort="Fisher, Julian" uniqKey="Fisher J" first="Julian" last="Fisher">Julian Fisher</name></region></country><country name="Brésil"><region name="État de Rio de Janeiro"><name sortKey="Goncalves, Lucio Souza" sort="Goncalves, Lucio Souza" uniqKey="Goncalves L" first="Lucio Souza" last="Gonçalves">Lucio Souza Gonçalves</name></region></country><country name="Espagne"><region name="Andalousie"><name sortKey="Llodra, Juan Carlos" sort="Llodra, Juan Carlos" uniqKey="Llodra J" first="Juan Carlos" last="Llodra">Juan Carlos Llodra</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001451 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001451 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32326426
|texte= COVID-19: A Recommendation to Examine the Effect of Mouthrinses with β-Cyclodextrin Combined with Citrox in Preventing Infection and Progression.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32326426" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |